Sleep disordered breathing in interstitial lung disease: A review

被引:1
作者
Lauren K Troy [1 ,2 ]
Tamera J Corte [1 ,2 ]
机构
[1] Department of Respiratory Medicine, Royal Prince Alfred Hospital, Camperdown, Sydney NSW 2050, Australia
[2] Sydney Medical School, University of Sydney, Sydney NSW 2006, Australia
关键词
Sleep disordered breathing; Interstitial lung disease; Pulmonary fibrosis; Nocturnal hypoxia; Obstructive sleep apnoea;
D O I
暂无
中图分类号
R766 [咽科学、咽疾病];
学科分类号
100213 ;
摘要
Patients with interstitial lung disease commonly exhibit abnormal sleep architecture and increased sleep fragmentation on polysomnography. Fatigue is a frequent complaint, and it is likely that poor sleep quality is a significant contributor. A number of studies have shown that sleep disordered breathing is prevalent in this population, particularly in the idiopathic pulmonary fibrosis subgroup. The factors that predispose these patients to obstructive sleep apnoea are not well understood, however it is believed that reduced caudal traction on the upper airway can enhance collapsibility. Ventilatory control system instability may also be an important factor, particularly in those with increased chemo-responsiveness, and in hypoxic conditions. Transient, repetitive nocturnal oxygen desaturation is frequently observed in interstitial lung disease, both with and without associated obstructive apnoeas. There is increasing evidence that sleep-desaturation is associated with increased mortality, and may be important in the pathogenesis of pulmonary hypertension in this population.
引用
收藏
页码:828 / 834
页数:7
相关论文
共 49 条
  • [1] This joint statement of the American Thoracic Society(ATS),and the European Respiratory Society(ERS)was adopted by the ATS board of directors,June2001and by the ERS Executive Committee,June2001. American Thoracic Society,European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. American Journal of Respiratory and Critical Care Medicine . 2002
  • [2] Does the abnormal pattern of breathing in patients with interstitial lung disease persist in deep, non-rapid eye movement sleep?. Shea S A,Winning A J,McKenzie E,Guz A. The American review of respiratory disease . 1989
  • [3] A double-blind trial of nocturnal supplemental oxygen for sleep desaturation in patients with chronic obstructive pulmonary disease and a daytime PaO2 above 60 mm Hg. Fletcher E C,Luckett R A,Goodnight-White S,Miller C C,Qian W,Costarangos-Galarza C. The American review of respiratory disease . 1992
  • [4] A randomized trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease patients. Chaouat A,Weitzenblum E,Kessler R,Charpentier C,Enrhart M,Schott R,Levi-Valensi P,Zielinski J,Delaunois L,Cornudella R,Moutinho dos Santos J. The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology . 1999
  • [5] Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group. Annals of Internal Medicine . 1980
  • [6] Long-term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Medical Research Council Working Party. Lancet,The . 1981
  • [7] Monitoring of nocturnal oxygen desaturation using pulse oximeter and apnomonitor in patients with chronic pulmonary disease. Miyahara Y,Miyahara Y,Naito T,Ikeda S. Respiration; international review of thoracic diseases . 1995
  • [8] Hypoxemia during apnea in normal subjects: mechanisms and impact of lung volume. L. J. Findley,A. L. Ries,G. M. Tisi,P. D. Wagn. Journal of Applied Physiology . 1983
  • [9] Arterial oxygen desaturation during sleep in interstitial pulmonary disease. Correlation with chemical control of breathing during wakefulness. Tatsumi K,Kimura H,Kunitomo F,Kuriyama T,Honda Y. Chest . 1989
  • [10] Sleep disruption in systemic sclerosis (scleroderma) patients: clinical and polysomnographic findings[J] .  &nbspSleep Medicine . 2002 (4)